Objective informational resource
for industry professionals

Вас может заинтересовать:

Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
WEB only
Lekhim has entered into a sublicense agreement with the Medicines Patent Pool to produce a generic version of the oral antiviral drug encitrelvir
On June 26, 2023, the Japanese Pharmaceutical Company Shionogi & Co., Ltd and the Medicines Patent Pool (MPP), a United Nations-backed international public health organization, have announced the signature of…
A new location for CMP Phar.ma
WEB only
A new location for CMP Phar.ma
An investment of seven million Euros. A new site of 5 thousand new square metres, more than half to be used for production. And a doubling - from today’s 42 to 80 - of the workforce…
X

error

Подобається наш журнал! Розкажи про нас

RSS
Follow by Email
Facebook
Twitter
LinkedIn
LinkedIn
Share
Для копіювання будь-ласка увійдіть в свій аккаунт